A 3-Amino-4-hydroxy-3-cyclobutene-1,2-dione-Containing Glutamate Analogue Exhibiting High Affinity to Excitatory Amino Acid Receptors

Philip C.M. Chan, Robert J Roon, James F. Koerner, Nicholas J. Taylor, John F. Honek

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The syntheses of several novel N-(hydroxydioxocyclobutenyl)-containing analogues of γ-aminobutyric acid and l-glutamate were undertaken to test the hypothesis that derivatives of 3,4-dihydroxy-3-cyclobutene-1,2-dione (squaric acid), such as 3-amino-4-hydroxy-3-cyclobutene-1,2-dione, could serve as a replacement for the carboxylate moiety in neurochemically interesting molecules. The syntheses were successfully accomplished by preparation of a suitably protected diamine or diamino acid followed by reaction with diethyl squarate. Subsequent deprotection resulted in the isolation of the corresponding N-(hydroxydioxocyclobutenyl)-containing analogues 13, 14, and 18. These analogues were screened as displacers in various neurochemical binding site assays. The l-glutamate analogue 18, which showed high affinity as a displacer for kainate and AMPA binding, was also examined for agonist potency for CA1 pyramidal neurons of the rat hippocampal slice preparation. It rivaled AMPA as one of the most potent agonists for depolarizing pyramidal neurons in medium containing 2.4 mM Mg+2 ions in which kainate/AMPA receptors are active but NMDA receptors are inhibited (IC50 = 1.1 μM). It was 1 order of magnitude less potent for depolarizing pyramidal neurons under conditions in which kainate/AMPA receptors were inhibited by 10 μM CNQX but NMDA receptors were active in 0.1 mM Mg-2-containing medium (IC50 = 10 μM). Compound 18 did not induce sensitization of CA1 pyramidal cells to depolarization by phosphonate analogues of glutamate (the QUIS-effect).

Original languageEnglish (US)
Pages (from-to)4433-4438
Number of pages6
JournalJournal of Medicinal Chemistry
Volume38
Issue number22
DOIs
StatePublished - Oct 1 1995

Fingerprint

Pyramidal Cells
Glutamate Receptors
Glutamic Acid
Kainic Acid Receptors
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
AMPA Receptors
N-Methyl-D-Aspartate Receptors
Inhibitory Concentration 50
6-Cyano-7-nitroquinoxaline-2,3-dione
Aminobutyrates
Organophosphonates
Diamines
Kainic Acid
Binding Sites
Ions
Acids
3-cyclobutene-1,2-dione

Cite this

A 3-Amino-4-hydroxy-3-cyclobutene-1,2-dione-Containing Glutamate Analogue Exhibiting High Affinity to Excitatory Amino Acid Receptors. / Chan, Philip C.M.; Roon, Robert J; Koerner, James F.; Taylor, Nicholas J.; Honek, John F.

In: Journal of Medicinal Chemistry, Vol. 38, No. 22, 01.10.1995, p. 4433-4438.

Research output: Contribution to journalArticle

Chan, Philip C.M. ; Roon, Robert J ; Koerner, James F. ; Taylor, Nicholas J. ; Honek, John F. / A 3-Amino-4-hydroxy-3-cyclobutene-1,2-dione-Containing Glutamate Analogue Exhibiting High Affinity to Excitatory Amino Acid Receptors. In: Journal of Medicinal Chemistry. 1995 ; Vol. 38, No. 22. pp. 4433-4438.
@article{63ebbc1019f045b6be70a5dc39e2bfc3,
title = "A 3-Amino-4-hydroxy-3-cyclobutene-1,2-dione-Containing Glutamate Analogue Exhibiting High Affinity to Excitatory Amino Acid Receptors",
abstract = "The syntheses of several novel N-(hydroxydioxocyclobutenyl)-containing analogues of γ-aminobutyric acid and l-glutamate were undertaken to test the hypothesis that derivatives of 3,4-dihydroxy-3-cyclobutene-1,2-dione (squaric acid), such as 3-amino-4-hydroxy-3-cyclobutene-1,2-dione, could serve as a replacement for the carboxylate moiety in neurochemically interesting molecules. The syntheses were successfully accomplished by preparation of a suitably protected diamine or diamino acid followed by reaction with diethyl squarate. Subsequent deprotection resulted in the isolation of the corresponding N-(hydroxydioxocyclobutenyl)-containing analogues 13, 14, and 18. These analogues were screened as displacers in various neurochemical binding site assays. The l-glutamate analogue 18, which showed high affinity as a displacer for kainate and AMPA binding, was also examined for agonist potency for CA1 pyramidal neurons of the rat hippocampal slice preparation. It rivaled AMPA as one of the most potent agonists for depolarizing pyramidal neurons in medium containing 2.4 mM Mg+2 ions in which kainate/AMPA receptors are active but NMDA receptors are inhibited (IC50 = 1.1 μM). It was 1 order of magnitude less potent for depolarizing pyramidal neurons under conditions in which kainate/AMPA receptors were inhibited by 10 μM CNQX but NMDA receptors were active in 0.1 mM Mg-2-containing medium (IC50 = 10 μM). Compound 18 did not induce sensitization of CA1 pyramidal cells to depolarization by phosphonate analogues of glutamate (the QUIS-effect).",
author = "Chan, {Philip C.M.} and Roon, {Robert J} and Koerner, {James F.} and Taylor, {Nicholas J.} and Honek, {John F.}",
year = "1995",
month = "10",
day = "1",
doi = "10.1021/jm00022a007",
language = "English (US)",
volume = "38",
pages = "4433--4438",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "22",

}

TY - JOUR

T1 - A 3-Amino-4-hydroxy-3-cyclobutene-1,2-dione-Containing Glutamate Analogue Exhibiting High Affinity to Excitatory Amino Acid Receptors

AU - Chan, Philip C.M.

AU - Roon, Robert J

AU - Koerner, James F.

AU - Taylor, Nicholas J.

AU - Honek, John F.

PY - 1995/10/1

Y1 - 1995/10/1

N2 - The syntheses of several novel N-(hydroxydioxocyclobutenyl)-containing analogues of γ-aminobutyric acid and l-glutamate were undertaken to test the hypothesis that derivatives of 3,4-dihydroxy-3-cyclobutene-1,2-dione (squaric acid), such as 3-amino-4-hydroxy-3-cyclobutene-1,2-dione, could serve as a replacement for the carboxylate moiety in neurochemically interesting molecules. The syntheses were successfully accomplished by preparation of a suitably protected diamine or diamino acid followed by reaction with diethyl squarate. Subsequent deprotection resulted in the isolation of the corresponding N-(hydroxydioxocyclobutenyl)-containing analogues 13, 14, and 18. These analogues were screened as displacers in various neurochemical binding site assays. The l-glutamate analogue 18, which showed high affinity as a displacer for kainate and AMPA binding, was also examined for agonist potency for CA1 pyramidal neurons of the rat hippocampal slice preparation. It rivaled AMPA as one of the most potent agonists for depolarizing pyramidal neurons in medium containing 2.4 mM Mg+2 ions in which kainate/AMPA receptors are active but NMDA receptors are inhibited (IC50 = 1.1 μM). It was 1 order of magnitude less potent for depolarizing pyramidal neurons under conditions in which kainate/AMPA receptors were inhibited by 10 μM CNQX but NMDA receptors were active in 0.1 mM Mg-2-containing medium (IC50 = 10 μM). Compound 18 did not induce sensitization of CA1 pyramidal cells to depolarization by phosphonate analogues of glutamate (the QUIS-effect).

AB - The syntheses of several novel N-(hydroxydioxocyclobutenyl)-containing analogues of γ-aminobutyric acid and l-glutamate were undertaken to test the hypothesis that derivatives of 3,4-dihydroxy-3-cyclobutene-1,2-dione (squaric acid), such as 3-amino-4-hydroxy-3-cyclobutene-1,2-dione, could serve as a replacement for the carboxylate moiety in neurochemically interesting molecules. The syntheses were successfully accomplished by preparation of a suitably protected diamine or diamino acid followed by reaction with diethyl squarate. Subsequent deprotection resulted in the isolation of the corresponding N-(hydroxydioxocyclobutenyl)-containing analogues 13, 14, and 18. These analogues were screened as displacers in various neurochemical binding site assays. The l-glutamate analogue 18, which showed high affinity as a displacer for kainate and AMPA binding, was also examined for agonist potency for CA1 pyramidal neurons of the rat hippocampal slice preparation. It rivaled AMPA as one of the most potent agonists for depolarizing pyramidal neurons in medium containing 2.4 mM Mg+2 ions in which kainate/AMPA receptors are active but NMDA receptors are inhibited (IC50 = 1.1 μM). It was 1 order of magnitude less potent for depolarizing pyramidal neurons under conditions in which kainate/AMPA receptors were inhibited by 10 μM CNQX but NMDA receptors were active in 0.1 mM Mg-2-containing medium (IC50 = 10 μM). Compound 18 did not induce sensitization of CA1 pyramidal cells to depolarization by phosphonate analogues of glutamate (the QUIS-effect).

UR - http://www.scopus.com/inward/record.url?scp=0028832196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028832196&partnerID=8YFLogxK

U2 - 10.1021/jm00022a007

DO - 10.1021/jm00022a007

M3 - Article

C2 - 7473569

AN - SCOPUS:0028832196

VL - 38

SP - 4433

EP - 4438

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 22

ER -